BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34977001)

  • 1. ITGB1 Drives Hepatocellular Carcinoma Progression by Modulating Cell Cycle Process Through PXN/YWHAZ/AKT Pathways.
    Xie J; Guo T; Zhong Z; Wang N; Liang Y; Zeng W; Liu S; Chen Q; Tang X; Wu H; Zhang S; Ma K; Wang B; Ou Y; Gu W; Chen H; Qiu Y; Duan Y
    Front Cell Dev Biol; 2021; 9():711149. PubMed ID: 34977001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-497 defect contributes to gastric cancer tumorigenesis and progression via regulating CDC42/ITGB1/FAK/PXN/AKT signaling.
    Zhang L; Yao L; Zhou W; Tian J; Ruan B; Lu Z; Deng Y; Li Q; Zeng Z; Yang D; Shang R; Xu M; Zhang M; Cheng D; Yang Y; Ding Q; Yu H
    Mol Ther Nucleic Acids; 2021 Sep; 25():567-577. PubMed ID: 34589278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin alpha 6 is upregulated and drives hepatocellular carcinoma progression through integrin α6β4 complex.
    Zheng G; Bouamar H; Cserhati M; Zeballos CR; Mehta I; Zare H; Broome L; Hu R; Lai Z; Chen Y; Sharkey FE; Rani M; Halff GA; Cigarroa FG; Sun LZ
    Int J Cancer; 2022 Sep; 151(6):930-943. PubMed ID: 35657344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA linc-ITGB1 promotes cell proliferation and migration in human hepatocellular carcinoma cells.
    Shang M; Xu X; Zhang M; Yang H
    Exp Ther Med; 2017 Nov; 14(5):4687-4692. PubMed ID: 29201168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.
    Zhao JF; Zhao Q; Hu H; Liao JZ; Lin JS; Xia C; Chang Y; Liu J; Guo AY; He XX
    Mol Ther Nucleic Acids; 2018 Jun; 11():538-553. PubMed ID: 29858089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway.
    Guo D; Zhang D; Ren M; Lu G; Zhang X; He S; Li Y
    FASEB J; 2020 Aug; 34(8):10668-10681. PubMed ID: 32567740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway.
    Xu X; Zhang X; Zhang Y; Wang Z
    Biomed Pharmacother; 2021 Jun; 138():111439. PubMed ID: 33684690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
    Wei GY; Hu M; Zhao L; Guo WS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin α2β1-mediated FAK and AKT activation.
    Tang Y; Xu Z; Xu F; Ye J; Chen J; He J; Chen Y; Qi C; Huang H; Liu R; Shan H; Xiao F
    JHEP Rep; 2023 Dec; 5(12):100903. PubMed ID: 37965158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA Paired-Related Homeobox 1 Promotes Gastric Carcinoma Cell Progression via Regulating MicroRNA-665/YWHAZ Axis.
    Liu W; Hu W; Hou K; Zhu S
    Dig Dis Sci; 2021 Nov; 66(11):3842-3853. PubMed ID: 33201331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling.
    Zheng W; Shen GL; Xu KY; Yin QQ; Hui TC; Zhou ZW; Xu CA; Wang SH; Wu WH; Shi LF; Pan HY
    World J Gastrointest Oncol; 2022 Jan; 14(1):253-264. PubMed ID: 35116115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.
    Li H; Miao Q; Xu CW; Huang JH; Zhou YF; Wu MJ
    J Korean Med Sci; 2016 Aug; 31(8):1215-23. PubMed ID: 27478331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.
    Chen DL; Wang ZQ; Ren C; Zeng ZL; Wang DS; Luo HY; Wang F; Qiu MZ; Bai L; Zhang DS; Wang FH; Li YH; Xu RH
    J Transl Med; 2013 Nov; 11():277. PubMed ID: 24180516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta (YWHAZ) Overcomes Drug Resistance and Tumorigenicity in Ovarian Cancer.
    Hong L; Chen W; Xing A; Wu D; Wang S
    Cell Physiol Biochem; 2018; 49(1):53-64. PubMed ID: 30134224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
    Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S
    Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ-SERPINE2 promotes the development of gastric carcinoma by sponging miR-375 and modulating YWHAZ.
    Liu J; Song S; Lin S; Zhang M; Du Y; Zhang D; Xu W; Wang H
    Cell Prolif; 2019 Jul; 52(4):e12648. PubMed ID: 31199037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-613 functions as tumor suppressor in hepatocellular carcinoma by targeting YWHAZ.
    Jiang X; Wu J; Zhang Y; Wang S; Yu X; Li R; Huang X
    Gene; 2018 Jun; 659():168-174. PubMed ID: 29551505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
    Chen DL; Wang DS; Wu WJ; Zeng ZL; Luo HY; Qiu MZ; Ren C; Zhang DS; Wang ZQ; Wang FH; Li YH; Kang TB; Xu RH
    Carcinogenesis; 2013 Apr; 34(4):803-11. PubMed ID: 23275153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long noncoding RNA linc-ITGB1 suppresses migration, invasion of hepatocellular carcinoma via regulating ZEB1.
    Yu WW; Wang K; Liao GJ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5089-5095. PubMed ID: 29228420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.